✦ LIBER ✦

Successful chemotherapy for newly diagnosed aggressive oligodendroglioma

✍ Scribed by David R. Macdonald; Laurie E. Gaspar; J. Gregory Cairncross

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 362 KB
Volume: 27
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410270519

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful chemotherapy for recurrent ma

Successful chemotherapy for recurrent malignant oligodendroglioma

✍ Dr. J. Gregory Cairncross; David R. Macdonald 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

Preirradiation gemcitabine chemotherapy

Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma : A Phase II study

✍ Michael Weller; Johannes Streffer; Wolfgang Wick; Rolf D. Kortmann; Eckart Heiss 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Addition of muramyl tripeptide to chemot

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma : A report from the Children's Oncology Group

✍ Alexander J. Chou; Eugenie S. Kleinerman; Mark D. Krailo; Zhengjia Chen; Donna L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 2 views

A multicentre phase II trial of gemcitab

A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03

✍ F. Hitz; G. Martinelli; E. Zucca; R. von Moos; W. Mingrone; M. Simcock; J. Peter 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract Mantle cell lymphoma (MCL) has a poor prognosis with often short and incomplete remissions. We aimed to test the efficacy and tolerability of gemcitabine in treating MCL. Gemcitabine was given in doses of 1000 mg/m^2^ as a 30 min infusion on days 1 and 8 of each 3 week cycle for a maxim

Primary chemotherapy for newly diagnosed

Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : Result of a randomized pilot study

✍ Dae Ho Lee; Ji-Youn Han; Heung Tae Kim; Sung Jin Yoon; Hong Ryull Pyo; Kwan Ho C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## BACKGROUND. This randomized pilot trial investigated whether primary chemotherapy was feasible in terms of efficacy, survival, toxicity profile, and quality of life compared with whole‐brain radiotherapy (WBRT) given first in chemotherapy‐naive patients nonsmall cell lung cancer (NS

Up-front chemotherapy and radiation trea

Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases : Survey by Outcome Research Network for Evaluation of Treatment Results in Oncology

✍ Luca Moscetti; Fabrizio Nelli; Alessandra Felici; Massimo Rinaldi; Stefano De Sa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## BACKGROUND. For patients with stage IV nonsmall cell lung cancer (NSCLC) who present with brain metastasis (BMs), standard platinum‐based chemotherapy regimens have challenged the role of up‐front whole‐brain radiotherapy (WBRT). ## METHODS. In this survey, the authors analyzed th